Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Augustin, M; Bewley, A; Brüggen, MC; de Bruin-Weller, MS; Ezzedine, K; Ferrucci, SM; Gkalpakiotis, S; Herranz, P; Johansson, EK; Kampe, T; Lapeere, H; Legat, FJ; Rehbinder, EM; Szepietowski, JC; Torres, T; Vestergaard, C; Werfel, T; Domenech, A; Massana, E; Koscielny, V; Narayanan, S; Kasujee, I; Gutermuth, J.
European, multicentre, prospective observational phase IV clinical study to assess the impact of lebrikizumab on health-related well-being and control of skin manifestations in patients with moderate-to-severe atopic dermatitis (ADTrust): study protocol
BMJ OPEN. 2025; 15(7): e102155
Doi: 10.1136/bmjopen-2025-102155
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Legat Franz
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Introduction Atopic dermatitis (AD) is a chronic, relapsing, heterogeneous skin disease affecting 2%-7% of adults, with roughly 30% having moderate-to-severe disease. AD symptoms, like intense itching and skin pain, carry a substantial disease burden that negatively impacts patients' quality of lif####
- Find related publications in this database (Keywords)
- Adult dermatology
- Observational Study
- Quality of Life